Provided by Tiger Fintech (Singapore) Pte. Ltd.

Nautilus Biotechnolgy, Inc.

0.7137
-0.0113-1.56%
Volume:204.99K
Turnover:146.31K
Market Cap:90.03M
PE:-1.31
High:0.7300
Open:0.7261
Low:0.7003
Close:0.7250
Loading ...

Company Profile

Company Name:
Nautilus Biotechnolgy, Inc.
Exchange:
NASDAQ
Establishment Date:
2016
Employees:
134
Office Location:
2701 Eastlake Avenue East,Seattle,Washington,United States
Zip Code:
98102
Fax:
- -
Introduction:
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was incorporated in 2016 and is headquartered in Seattle, Washington.

Directors

Name
Position
Adam Stone
Chief Executive Officer and Director
Joseph Edelman
Chairman
Michael Altman
Chief Financial Officer and Director
Bradley L. Campbell
Director
Saqib Islam
Director
Todd Wider
Director

Shareholders

Name
Position
Adam Stone
Chief Executive Officer and Director
Michael Altman
Chief Financial Officer and Director
Konstantin Poukalov
Chief Business Officer